Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cdfcf975092110ad153f8af470345bf6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7dfe6a0b58eafa796df8153e2460c2b8 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 |
filingDate |
2003-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d64fbb44664a4161929cde8d9d99baf2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_149ead7e37f914a050e0a89521b84254 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18b8561e5056671ab9d378eb5109624a |
publicationDate |
2004-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2500716-A1 |
titleOfInvention |
Compositions comprising highly purified amphotericin b |
abstract |
A method for treating fungal infections in a mammal that comprises administering a therapeutically effective amount of a composition comprising amphotericin B and a pharmaceutically acceptable carrier, wherein the amphotericin B is substantially pure. |
priorityDate |
2002-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |